Marburg Virus Viral Protein 35 Inhibits Protein Kinase R Activation in a Cell Type-Specific Manner

The Journal of Infectious Diseases
Adam J Hume, Elke Mühlberger

Abstract

Protein kinase R (PKR) is a key antiviral protein involved in sensing and restricting viral infections. Here we analyzed the ability of Marburg virus (MARV) viral protein 35 (VP35) to inhibit PKR activation in human and bat cells. Similar to the related Ebola and Lloviu viruses, MARV VP35 was able to inhibit PKR activation in 293T cells. In contrast, we found that MARV VP35 did not inhibit human or bat PKR activation in human glioblastoma U-251-MG cells or a Rousettus aegyptiacus cell line. Additional experiments revealed that PACT, a known PKR regulator, was insufficient to rescue the ability of VP35 to inhibit PKR activation in these cells. Taken together, this study indicates that the ability of VP35 to inhibit PKR is cell type specific, potentially explaining discrepancies between the ability of filoviruses to potently block innate immune responses, and the high levels of interferon and interferon-stimulated genes observed in filovirus patients.

References

Oct 20, 2001·The Journal of Biological Chemistry·S BannwarthA Gatignol
Dec 14, 2005·Journal of Molecular Biology·Sylvie BannwarthAnne Gatignol
Sep 18, 2008·The Journal of General Virology·Benjamin G HaleDavid Jackson
Oct 22, 2008·Molecular and Cellular Biology·Aïcha DaherAnne Gatignol
Nov 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·James E StrongHeinz Feldmann
Jun 12, 2009·Journal of Virology·Michael SchümannElke Mühlberger
Jul 21, 2009·Pharmacology & Therapeutics·Paola M BarralPaul B Fisher
Aug 4, 2009·PLoS Pathogens·Jonathan S TownerPierre E Rollin
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christopher R KimberlinErica Ollmann Saphire
Jan 19, 2010·Nature Structural & Molecular Biology·Daisy W LeungGaya K Amarasinghe
Nov 15, 2011·The Journal of Infectious Diseases·Annika KühlStefan Pöhlmann
Dec 1, 2009·Viruses·Bianca Dauber, Thorsten Wolff
Nov 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Parameshwaran RamananGaya K Amarasinghe
Sep 12, 2013·Retrovirology·Guerline ClerziusAnne Gatignol
Nov 7, 2014·Journal of Wildlife Diseases·Brian R AmmanJonathan S Towner
Jan 30, 2015·Wiley Interdisciplinary Reviews. RNA·Alex HeyamMichael Plevin
Apr 4, 2015·The Journal of Infectious Diseases·Janusz T PaweskaAlan Kemp
Jul 24, 2015·Journal of Virology·John H ConnorArthur J Goff
Oct 7, 2015·Nature Reviews. Microbiology·Ilhem MessaoudiChristopher F Basler
Feb 16, 2016·Cell Reports·Megan R EdwardsChristopher F Basler
Jun 9, 2016·FEMS Microbiology Reviews·Robin BurkJens H Kuhn
Jan 27, 2017·Journal of Virology·Ivan V KuzminAlexander Bukreyev
Nov 21, 2017·Cell Host & Microbe·Amie J EisfeldYoshihiro Kawaoka
Apr 11, 2018·Archives of Virology·Gaya K AmarasingheJens H Kuhn

❮ Previous
Next ❯

Citations

Apr 17, 2020·Journal of Virology·Caroline G WilliamsChristopher F Basler
Feb 23, 2019·Vaccines·Beatriz Escudero-Pérez, César Muñoz-Fontela
May 28, 2019·F1000Research·Judith OlejnikAdam J Hume

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.